CTAG1B and non-small cell lung carcinoma: Another vaccine employing Chimpanzee Adenovirus Oxford 1 (ChAdOx1‐MAGEA3‐NY‐ESO‐1) is underway to evaluate along with chemotherapy and an immune checkpoint inhibitor for patients with NSCLC in phase I/IIa trial (NCT04908111).